---
schema_version: "secwatch.filing_event.v1"
accession: "0001490978-26-000059"
form_type: "8-K"
ticker: "SDGR"
cik: "0001490978"
company_name: "Schrodinger, Inc."
filed_at: "2026-06-29T20:29:15+00:00"
generated_at: "2026-06-29T20:30:16.259337+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Schrödinger receives $57M from Lilly's acquisition of co-founded Ajax Therapeutics

## Summary
- Received ~$57M cash from Eli Lilly's acquisition of Ajax Therapeutics, a company co-founded by Schrödinger.
- Eligible for additional cash payments upon achievement of specified clinical and regulatory milestones by Ajax.
- Acquisition completed June 29, 2026; Ajax is a biotech company co-founded by Schrödinger.

## SEC filing metadata
- accession: 0001490978-26-000059
- form_type: 8-K
- ticker: SDGR
- cik: 0001490978
- company_name: Schrodinger, Inc.
- filed_at: 2026-06-29T20:29:15+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1490978/000149097826000059/0001490978-26-000059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1490978/000149097826000059/sdgr-20260629.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001490978-26-000059
- JSON: https://secwatch.observer/filing/0001490978-26-000059.json
- Plain text: https://secwatch.observer/filing/0001490978-26-000059.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.